FINAL EXAN NATIONAL BOARD OF EXAMINATIONS UNE 2012 CARDIOLOGY PAPER-I Timo: 3 hours cARD I Z081 Max. Marks : 100 Attempt all questions in order. Each question cari 10 marks. 1. Deserbe coagulation pathways and indicate where the anticoagulants S+5 interore 2. Describe the anatomy of tangle of Koch's Explain the mechanism of 34+3 paroxysmal junctional reciprocating tachycardia, How ist treated? 3. What are ypercoaguable states? What ae the laboratory tests for their +344 diagnosis? Outine management of hypercoaguiable sate 4. Describe invasive and nondnvasive evaluation of pulmonary arterial +344 hypertension, How wil you assess reversibly? 5. Whatls coronary ow reserve? Describe its clinical significance. 5+ 6. Discuss genetics & manifestation of venicularnon-compaction. 545 7. Describe embryogenesis of conctruncal anomalies. Classy double 44343 cute right ventricle and conelate with manifestations 8. Describe Fick principe and estimation of cardiac ouput by tis principle 545 © Discuss the principles and cardiovascular applications of Optical 515 Coherence Tomography (OCT) 10, Discuss genetes of long QT syndrome & ts clinical relevance. 58FINAL EXAM NATIONAL BOARD OF EXAMINATIONS JUNE DON CARDIOLOGY PAPER-I| Time: 3 hours CCARDIUIA205m Max. Marks : 100 ‘Attompt all questions in order. Each question carries 10 marks. Outine the manifestation, evaluation, diagnosis and management of HENEF (Heart Failure with Normal Ejection Fraction). Describe etiopathogenesis and evaluation of left main coronary disease [Whats the current status of its management? Describe in brief the role of left atrial appendage in thromboembolism, utine curent status of eft ail appendage occluder devices Describe general principles, indications and regimens for infective endocaritis prophylaxis, ‘What are the causes and manifestation of loss of capture in cardiac pacing? Describe its diagnosis and management. \What is the etiopathogenesis, manifestation and management of ARVC (Arthythmogenic Right Ventricular Cardiomyopathy)? Deseribe antithrombotic therapy for non-cardiac surgery in post coronary stenting \What is peripartum cardiomyopathy? Discuss is risk factors, treatment and prognosis. Discuss etiology and management of pacemaker implant infection, 40. What is stent thrombosis? Discuss its etopathogenesis and diagnostic criteria aeseav2 eat 46 Sane 2424368 Dee eae 515 DatedFINAL EXAM NATIONAL BOARD OF EXAMINATIONS CARDIOLOGY, PAPER- IL Time: 3 hours CARDIU 205" Max. Marks : 100, ‘Attompt all questions in order. Each question carries 10 marks. Describe ‘COURAGE Tia. Whats the contribution ofthe tal to cinical practoe? Discuss the role of MRI in Ischemic cardiomyopathy, hypertrophic cardiomyopathy & arthythmogenic right ventricular dysplasia ‘What ae bioabsorbable stents? Outine their current status ‘What js micro T wave aterans? What is their role in cardiac arthythmogenesis? Discuss curent status of fetal cardac intervention Discuss current status of PFO (patent foramen ovale) in cardiovascular disease and PFO closure Discuss indications and current status of tissue heart valves, What are crug eluting balloons? What is their present status in interventions? What re leadless pacemakers? What isthe curent status of leadiess permanent cardiac pacing devices? 10. Discuss the role of renal denervation in treatment of hypertension 498 e384 37 37 37 55 55 10